BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2017 related articles for article (PubMed ID: 27649744)

  • 1. Extracellular Vesicles Released from Human Umbilical Cord-Derived Mesenchymal Stromal Cells Prevent Life-Threatening Acute Graft-Versus-Host Disease in a Mouse Model of Allogeneic Hematopoietic Stem Cell Transplantation.
    Wang L; Gu Z; Zhao X; Yang N; Wang F; Deng A; Zhao S; Luo L; Wei H; Guan L; Gao Z; Li Y; Wang L; Liu D; Gao C
    Stem Cells Dev; 2016 Dec; 25(24):1874-1883. PubMed ID: 27649744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Graft-Versus-Host Disease Amelioration by Human Bone Marrow Mesenchymal Stromal/Stem Cell-Derived Extracellular Vesicles Is Associated with Peripheral Preservation of Naive T Cell Populations.
    Fujii S; Miura Y; Fujishiro A; Shindo T; Shimazu Y; Hirai H; Tahara H; Takaori-Kondo A; Ichinohe T; Maekawa T
    Stem Cells; 2018 Mar; 36(3):434-445. PubMed ID: 29239062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. hUC-EVs-ATO reduce the severity of acute GVHD by resetting inflammatory macrophages toward the M2 phenotype.
    Su Y; Sun X; Liu X; Qu Q; Yang L; Chen Q; Liu F; Li Y; Wang Q; Huang B; Huang XJ; Zhang XH
    J Hematol Oncol; 2022 Jul; 15(1):99. PubMed ID: 35864538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal Stem Cell Derived Extracellular Vesicles: A Role in Hematopoietic Transplantation?
    De Luca L; Trino S; Laurenzana I; Lamorte D; Caivano A; Del Vecchio L; Musto P
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28486431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inducible Costimulator Gene-Transduced Bone Marrow-Derived Mesenchymal Stem Cells Attenuate the Severity of Acute Graft-Versus-Host Disease in Mouse Models.
    Yang D; Wang LP; Zhou H; Cheng H; Bao XC; Xu S; Zhang WP; Wang JM
    Cell Transplant; 2015; 24(9):1717-31. PubMed ID: 25203502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunomodulation effects of mesenchymal stromal cells on acute graft-versus-host disease after hematopoietic stem cell transplantation.
    Zhao K; Lou R; Huang F; Peng Y; Jiang Z; Huang K; Wu X; Zhang Y; Fan Z; Zhou H; Liu C; Xiao Y; Sun J; Li Y; Xiang P; Liu Q
    Biol Blood Marrow Transplant; 2015 Jan; 21(1):97-104. PubMed ID: 25300866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of bone marrow mesenchymal stem cells on hematopoietic recovery and acute graft-versus-host disease in murine allogeneic umbilical cord blood transplantation model.
    Li ZY; Wang CQ; Lu G; Pan XY; Xu KL
    Cell Biochem Biophys; 2014 Sep; 70(1):115-22. PubMed ID: 24696072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular vesicles derived from human umbilical cord mesenchymal stem cells alleviate rat hepatic ischemia-reperfusion injury by suppressing oxidative stress and neutrophil inflammatory response.
    Yao J; Zheng J; Cai J; Zeng K; Zhou C; Zhang J; Li S; Li H; Chen L; He L; Chen H; Fu H; Zhang Q; Chen G; Yang Y; Zhang Y
    FASEB J; 2019 Feb; 33(2):1695-1710. PubMed ID: 30226809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T Cell and Cytokine Dynamics in the Blood of Patients after Hematopoietic Stem Cell Transplantation and Multipotent Mesenchymal Stromal Cell Administration.
    Petinati N; Davydova Y; Nikiforova K; Bigildeev A; Belyavsky A; Arapidi G; Drize N; Kuzmina L; Parovichnikova E; Savchenko V
    Transplant Cell Ther; 2023 Feb; 29(2):109.e1-109.e10. PubMed ID: 36372356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel study on the immunomodulatory effect of umbilical cord derived mesenchymal stem cells pretreated with traditional Chinese medicine Asarinin.
    He H; Yang T; Li F; Zhang L; Ling X
    Int Immunopharmacol; 2021 Nov; 100():108054. PubMed ID: 34492537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prophylactic effect of TLR5 agonist flagellin on acute graft versus host disease after allogeneic hematopoietic stem cell transplantation and its mechanism].
    Gong XD; Ma LM; Zhu L; Guo HM; Ren LS; Ren RR; Zhang HP; Wei F; Niu YY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Aug; 20(4):965-70. PubMed ID: 22931665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone marrow-derived mesenchymal stem cells decrease acute graft-versus-host disease after allogeneic hematopoietic stem cells transplantation.
    Tian Y; Deng YB; Huang YJ; Wang Y
    Immunol Invest; 2008; 37(1):29-42. PubMed ID: 18214798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diverse impact of xeno-free conditions on biological and regenerative properties of hUC-MSCs and their extracellular vesicles.
    Bobis-Wozowicz S; Kmiotek K; Kania K; Karnas E; Labedz-Maslowska A; Sekula M; Kedracka-Krok S; Kolcz J; Boruczkowski D; Madeja Z; Zuba-Surma EK
    J Mol Med (Berl); 2017 Feb; 95(2):205-220. PubMed ID: 27638341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal stem cell exosome-derived miR-223 alleviates acute graft-versus-host disease via reducing the migration of donor T cells.
    Liu W; Zhou N; Liu Y; Zhang W; Li X; Wang Y; Zheng R; Zhang Y
    Stem Cell Res Ther; 2021 Feb; 12(1):153. PubMed ID: 33637123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of human umbilical cord derived mesenchymal stem cell therapy in children with severe aplastic anemia following allogeneic hematopoietic stem cell transplantation: a retrospective case series of 37 patients.
    Si Y; Yang K; Qin M; Zhang C; Du Z; Zhang X; Liu Y; Yue Y; Feng Z
    Pediatr Hematol Oncol; 2014 Feb; 31(1):39-49. PubMed ID: 24383400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of adipose tissue-derived mesenchymal stem cells by rapamycin in a murine model of acute graft-versus-host disease.
    Kim KW; Moon SJ; Park MJ; Kim BM; Kim EK; Lee SH; Lee EJ; Chung BH; Yang CW; Cho ML
    Stem Cell Res Ther; 2015 Oct; 6():202. PubMed ID: 26497134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular vesicles derived from mesenchymal stem cells prevent skin fibrosis in the cGVHD mouse model by suppressing the activation of macrophages and B cells immune response.
    Guo L; Lai P; Wang Y; Huang T; Chen X; Geng S; Huang X; Luo C; Wu S; Ling W; Huang L; Du X; Weng J
    Int Immunopharmacol; 2020 Jul; 84():106541. PubMed ID: 32402950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced alleviation of aGVHD by TGF-β1-modified mesenchymal stem cells in mice through shifting MΦ into M2 phenotype and promoting the differentiation of Treg cells.
    Wu R; Liu C; Deng X; Chen L; Hao S; Ma L
    J Cell Mol Med; 2020 Jan; 24(2):1684-1699. PubMed ID: 31782262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial microparticles delivering microRNA-155 into T lymphocytes are involved in the initiation of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.
    Zhang R; Wang X; Hong M; Luo T; Zhao M; Shen H; Fang J; Li X; Zang S; Chen P; Nie D; Zheng P; Wu Q; Xia L
    Oncotarget; 2017 Apr; 8(14):23360-23375. PubMed ID: 28423578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular Vesicles Improve Post-Stroke Neuroregeneration and Prevent Postischemic Immunosuppression.
    Doeppner TR; Herz J; Görgens A; Schlechter J; Ludwig AK; Radtke S; de Miroschedji K; Horn PA; Giebel B; Hermann DM
    Stem Cells Transl Med; 2015 Oct; 4(10):1131-43. PubMed ID: 26339036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 101.